指南与共识中枢神经肿瘤放疗放疗物理与技术

神经肿瘤危及器官放疗剂量限值:欧洲粒子治疗网络共识

Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus.
指南 / 共识 · Radiother Oncol · 2018-05-17

该共识由欧洲粒子治疗网络组织20位神经肿瘤放疗专家制定,基于系统检索正常分次光子与粒子治疗的危及器官剂量限值文献,汇总了神经肿瘤危及器官的推荐剂量限值及对应正常组织并发症概率水平,并建议用于光子与质子束模型比较及前瞻性临床试验。

要点

  • 共识推荐神经肿瘤危及器官剂量限值按ICRU建议关联特定NTCP水平。
  • 对NTCP数据缺乏或不足的危及器官,提出高效数据收集方案。
  • 推荐将该共识限值用于光子与质子束模型比较及新技术临床试验。

核心结论

  • 推荐使用本共识汇总的欧洲粒子治疗网络危及器官剂量限值,用于光子与质子束照射的模型比较及包含新放疗技术和/或 modalities 的前瞻性临床试验。

研究设计与样本

  • 通过系统检索PubMed、Ovid Medline、Cochrane Library、Embase和Web of Science识别正常分次光子与粒子治疗中危及器官剂量限值的当前文献,并交叉核对纳入文献的参考文献列表。
  • 由20位神经肿瘤放疗领域专家达成共识。

主要发现

  • 对神经肿瘤文献中已发表的危及器官,汇总现有文献并根据近期ICRU建议推荐与特定正常组织并发症概率水平相关的剂量限值。
  • 对正常组织并发症概率数据缺乏或不足的危及器官,提出有效且高效的数据收集建议。

临床怎么用

  • 在比较光子与质子束照射的模型化方法中采用本共识的危及器官剂量限值。
  • 在包含新放疗技术和/或 modalities 的前瞻性临床试验中采用本共识的危及器官剂量限值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: For unbiased comparison of different radiation modalities and techniques, consensus on delineation of radiation sensitive organs at risk (OARs) and on their dose constraints is warranted. Following the publication of a digital, online atlas for OAR delineation in neuro-oncology by the same group, we assessed the brain OAR-dose constraints in a follow-up study. METHODS: We performed a comprehensive search to identify the current papers on OAR dose constraints for normofractionated photon and particle therapy in PubMed, Ovid Medline, Cochrane Library, Embase and Web of Science. Moreover, the included articles' reference lists were cross-checked for potential studies that met the inclusion criteria. Consensus was reached among 20 radiation oncology experts in the field of neuro-oncology. RESULTS: For the OARs published in the neuro-oncology literature, we summarized the available literature and recommended dose constraints associated with certain levels of normal tissue complication probability (NTCP) according to the recent ICRU recommendations. For those OARs with lacking or insufficient NTCP data, a proposal for effective and efficient data collection is given. CONCLUSION: The use of the European Particle Therapy Network-consensus OAR dose constraints summarized in this article is recommended for the model-based approach comparing photon and proton beam irradiation as well as for prospective clinical trials including novel radiation techniques and/or modalities.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Lambrecht M, Eekers DBP, Alapetite C, et al. Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus. Radiother Oncol. 2018. PMID: 29779919. doi:10.1016/j.radonc.2018.05.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。